Founded in 1989, Inflexxion specializes in the surveillance and analysis of emerging public health issues related to prescription drug abuse, substance use, behavioral health, and pain management.
With a mission to drive public health improvements within the industry, Inflexxion offers a continuum of solutions to healthcare organizations, provider communities, pharmaceutical companies, and regulatory authorities, providing data and analytic services to inform and support decision-making related to substance use disorders, including opioid addiction.
At its core, Inflexxion:
- Aggregates clinical patient data through its proprietary behavioral health assessment and pain-related suite of assessments, and offers Internet Monitoring technology and web-surveys with hard to reach populations.
- Analyzes and disseminates health-related data for quality improvement, outcome measurement, surveillance, risk management and epidemiological studies. Inflexxion launched the first real-world surveillance program for monitoring prescription opioid misuse and abuse, the National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO).
- Advances clinical outcomes, improves treatment, increases productivity, and lowers costs.